Oncimmune Share Forecast, Price & News

Oncimmune (LON:ONC) Frequently Asked Questions

How has Oncimmune's stock been impacted by Coronavirus?

Oncimmune's stock was trading at GBX 70.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ONC shares have increased by 127.0% and is now trading at GBX 160.
View which stocks have been most impacted by COVID-19.

When is Oncimmune's next earnings date?

Oncimmune is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Oncimmune.

How were Oncimmune's earnings last quarter?

Oncimmune Holdings plc (LON:ONC) issued its earnings results on Tuesday, February, 13th. The company reported ($5.70) earnings per share for the quarter. The firm earned $0.08 million during the quarter.
View Oncimmune's earnings history.

Who are Oncimmune's key executives?

Oncimmune's management team includes the following people:

• Dr. Adam Mark Hill Ph.D., CEO & Director (Age 41, Pay $385k)
• Mr. Matthew Hall, Chief Financial Officer
• Prof. Tariq Sethi M.D., B.Sc., M.A., Ph.D., FRCP, Chief Scientific Officer
• Ms. Cléa Rosenfeld, Head of Investor Relations
• Mr. Ron Kirschner, Gen. Counsel & Company Sec.
• Dr. James R. Jett M.D., Chief Medical Officer of US
• Mr. Maarten Brusse, Chief Commercial Officer of Asia
• Mr. Shane Smith, Sr. VP of Market Access & Reimbursement Oncimmune (Usa)
• Mr. Matthew Luttrell, Chief Commercial Officer
• Mr. Andrew Millet BA, FCA, MBA, Exec. (Age 54)

Who are some of Oncimmune's key competitors?

Some companies that are related to Oncimmune include Renalytix AI (RENX), Sernova (SVA), Profound Medical (PRN), Akumin (AKU), Profound Medical (PRN), Yourgene Health (YGEN), SQI Diagnostics (SQD), Verici Dx (VRCI), VentriPoint Diagnostics (VPT), Cambridge Cognition (COG), LexaGene (LXG), GeneNews (GEN), Abingdon Health (ABDX), genedrive (GDR) and LED Medical Diagnostics (LMD).
View all of ONC's competitors.

What other stocks do shareholders of Oncimmune own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oncimmune investors own include Actinium Pharmaceuticals (ATNM), Digi International (DGII), SeaChange International (SEAC), SMTC (SMTX), (APHA), (AQB), Axsome Therapeutics (AXSM), (BGSF), Chimerix (CMRX) and Constellation Pharmaceuticals (CNST).

What is Oncimmune's stock symbol?

Oncimmune trades on the London Stock Exchange (LON) under the ticker symbol "ONC."

How do I buy shares of Oncimmune?

Shares of ONC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Oncimmune's stock price today?

One share of ONC stock can currently be purchased for approximately GBX 160.

How much money does Oncimmune make?

Oncimmune has a market capitalization of £110.62 million and generates £3.72 million in revenue each year.

How many employees does Oncimmune have?

Oncimmune employs 72 workers across the globe.

What is Oncimmune's official website?

The official website for Oncimmune is oncimmune.com.

Where are Oncimmune's headquarters?

Oncimmune is headquartered at Hucknall Road, NOTTINGHAM, NG5 1PB, United Kingdom.

How can I contact Oncimmune?

Oncimmune's mailing address is Hucknall Road, NOTTINGHAM, NG5 1PB, United Kingdom. The company can be reached via phone at +44-115-8231869.